Business Description
Transgenic Group Inc
ISIN : JP3635720000
Total Employee Number:
308Description
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.02 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.44 | |||||
Debt-to-EBITDA | -343.74 | |||||
Interest Coverage | 3.01 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.23 | |||||
Beneish M-Score | -2.51 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.2 | |||||
3-Year EBITDA Growth Rate | 62.8 | |||||
3-Year FCF Growth Rate | 70.8 | |||||
3-Year Book Growth Rate | -7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 71.93 | |||||
9-Day RSI | 64.77 | |||||
14-Day RSI | 56.86 | |||||
3-1 Month Momentum % | -17.8 | |||||
6-1 Month Momentum % | -31.33 | |||||
12-1 Month Momentum % | 26.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.74 | |||||
Quick Ratio | 1.1 | |||||
Cash Ratio | 0.55 | |||||
Days Inventory | 84.19 | |||||
Days Sales Outstanding | 30.53 | |||||
Days Payable | 14.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.4 | |||||
Shareholder Yield % | 4.01 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 18.47 | |||||
Operating Margin % | 1.05 | |||||
Net Margin % | -0.59 | |||||
EBITDA Margin % | -0.05 | |||||
FCF Margin % | -0.32 | |||||
OCF Margin % | 0.2 | |||||
ROE % | -1.62 | |||||
ROA % | -0.8 | |||||
ROIC % | 0.97 | |||||
3-Year ROIIC % | 20.34 | |||||
ROC (Joel Greenblatt) % | -3.79 | |||||
ROCE % | -2.65 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio without NRI | 30.54 | |||||
Shiller PE Ratio | 42.47 | |||||
Price-to-Owner-Earnings | 33.87 | |||||
PS Ratio | 0.28 | |||||
PB Ratio | 0.8 | |||||
Price-to-Tangible-Book | 0.88 | |||||
Price-to-Operating-Cash-Flow | 145.89 | |||||
EV-to-EBIT | -23.47 | |||||
EV-to-EBITDA | -624.29 | |||||
EV-to-Revenue | 0.28 | |||||
EV-to-FCF | -88.77 | |||||
Price-to-GF-Value | 0.88 | |||||
Price-to-Projected-FCF | 1.18 | |||||
Price-to-Median-PS-Value | 0.43 | |||||
Price-to-Graham-Number | 1.1 | |||||
| Price-to-Net-Current-Asset-Value | 2.16 | |||||
Earnings Yield (Greenblatt) % | -4.26 | |||||
FCF Yield % | -1.12 | |||||
Forward Rate of Return (Yacktman) % | 29.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Transgenic Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 13,174.425 | ||
| EPS (TTM) (円) | -4.644 | ||
| Beta | -0.3964 | ||
| 3-Year Sharpe Ratio | 0.05 | ||
| 3-Year Sortino Ratio | 0.13 | ||
| Volatility % | 120.76 | ||
| 14-Day RSI | 56.86 | ||
| 14-Day ATR (円) | 7.1433 | ||
| 20-Day SMA (円) | 214.3 | ||
| 12-1 Month Momentum % | 26.9 | ||
| 52-Week Range (円) | 168 - 487 | ||
| Shares Outstanding (Mil) | 16.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Transgenic Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Transgenic Group Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| 100:1 Stock Split | 2013-03-27 | 1,067.00 (+11.15%) | ||
| 0.001:1 Stock Split | 2006-09-29 | 670.00 (+0.00%) |
Show
Entries
Transgenic Group Inc Frequently Asked Questions
What is Transgenic Group Inc(TSE:2342)'s stock price today?
The current price of TSE:2342 is 円227.00. The 52 week high of TSE:2342 is 円487.00 and 52 week low is 円168.00.
When is next earnings date of Transgenic Group Inc(TSE:2342)?
The next earnings date of Transgenic Group Inc(TSE:2342) is .
Does Transgenic Group Inc(TSE:2342) pay dividends? If so, how much?
Transgenic Group Inc(TSE:2342) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Transgenic Group Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers